Starting a GLP-1: A Beginner Guide to Choosing Well

Most people choose a GLP-1 provider the way they choose a streaming service — by the advertised monthly price. That is close to the least informative variable available. This guide covers what actually determines whether treatment works for you, in the order you should decide it.

How We Assessed These

Four decisions, in this order. Price is the last one, not the first.

Decide the Medication Before the Provider

The agents are not interchangeable. Tirzepatide (Zepbound) leads on weight reduction at above 20% in pivotal trials. Oral semaglutide 25 mg (the Wegovy pill) reached 16.6% in OASIS 4. Injectable semaglutide (Wegovy) sits near 14.9%. Orforglipron (Foundayo) reached 12.4% at the highest dose in ATTAIN-1 but has no fasting requirement and the lowest entry price.

Route matters as much as efficacy for adherence. A weekly injection suits some people; a daily pill with a 30-minute fasting window suits others; a daily pill with no restrictions suits people who could not manage either.

Understand What Will Actually Happen

Two things surprise most first-time patients, and both are predictable.

Side effects cluster during titration. Nausea, constipation, diarrhea and vomiting are most pronounced after starting and after each dose increase, then generally attenuate at a stable dose. Slower escalation is the most effective and most underused adjustment.

And stopping usually reverses the result. A Lancet analysis found people discontinuing GLP-1 therapy regain a majority of the weight lost. Plan for this as ongoing therapy from the outset rather than discovering it at month nine.

Set Up the Things That Determine Quality of Loss

Published estimates of lean mass loss on GLP-1 therapy range from roughly 15% to 60% of total weight lost, and the variables driving that range are largely yours to control.

Protein adequacy — guidance circulated by the AMA suggests 25-35 g per meal, every 3-4 hours — and resistance training two to three times weekly are the interventions with the strongest evidence. Start both at the beginning, not after you notice a problem.

Questions Worth Asking Before You Enrol

• Which medication are you recommending for me specifically, and why that one?
• What is the total cost at my expected maintenance dose?
• What happens if the side effects are bad — can we slow titration?
• What protein target and training guidance comes with this?
• How do I reach a clinician between visits?

A provider that answers these clearly is managing a treatment plan. One that deflects to a monthly price is selling a subscription.